First Time Loading...

4D Molecular Therapeutics Inc
NASDAQ:FDMT

Watchlist Manager
4D Molecular Therapeutics Inc Logo
4D Molecular Therapeutics Inc
NASDAQ:FDMT
Watchlist
Price: 26.38 USD 3.9% Market Closed
Updated: May 3, 2024

Income Statement

Earnings Waterfall
4D Molecular Therapeutics Inc

Revenue
20.7m USD
Operating Expenses
-133.6m USD
Operating Income
-112.9m USD
Other Expenses
12m USD
Net Income
-100.8m USD

Income Statement
4D Molecular Therapeutics Inc

Rotate your device to view
Income Statement
Currency: USD
Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
1
N/A
16
+1 429%
17
+9%
18
+6%
17
-4%
3
-84%
2
-31%
3
+59%
2
-29%
2
+4%
22
+860%
21
-6%
Operating Income
Operating Expenses
(38)
(60)
(84)
(89)
(99)
(105)
(108)
(113)
(116)
(120)
(127)
(134)
Selling, General & Administrative
(12)
(19)
(28)
(28)
(31)
(32)
(32)
(33)
(33)
(33)
(34)
(36)
Research & Development
(25)
(41)
(56)
(61)
(68)
(73)
(76)
(80)
(83)
(86)
(93)
(97)
Operating Income
(37)
N/A
(44)
-21%
(67)
-51%
(71)
-6%
(81)
-14%
(102)
-26%
(106)
-4%
(110)
-4%
(114)
-3%
(117)
-3%
(105)
+11%
(113)
-8%
Pre-Tax Income
Interest Income Expense
0
0
0
0
0
1
1
3
4
6
9
12
Total Other Income
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
(0)
Pre-Tax Income
(37)
N/A
(45)
-21%
(67)
-50%
(71)
-7%
(81)
-14%
(102)
-25%
(105)
-3%
(107)
-2%
(110)
-2%
(111)
-1%
(96)
+14%
(101)
-5%
Net Income
Income from Continuing Operations
(37)
(45)
(67)
(71)
(81)
(102)
(105)
(107)
(110)
(111)
(96)
(101)
Net Income (Common)
(37)
N/A
(45)
-21%
(67)
-50%
(71)
-7%
(81)
-14%
(102)
-25%
(105)
-3%
(107)
-2%
(110)
-2%
(111)
-1%
(96)
+14%
(101)
-5%
EPS (Diluted)
-1.38
N/A
-1.66
-20%
-2.47
-49%
-2.57
-4%
-2.52
+2%
-3.14
-25%
-3.24
-3%
-3.32
-2%
-3.35
-1%
-2.9
+13%
-2.27
+22%
-2.58
-14%

See Also

Discover More